Category diabetes drugs

What is Galvus? Galvus is a drug containing the active substance vildagliptin, available in white to slightly yellowish, round-shaped tablets (50 mg). What is Galvus used for? Galvus is indicated in the treatment of type 2 diabetes mellitus (non-insulin-dependent diabetes). It is used in combination with another antidiabetic medicine (in "dual therapy"), when the patient's diabetes is not sufficiently controlled by the other drug taken alone

GALVUS ® a drug based on Vidagliptin THERAPEUTIC GROUP: Oral hypoglycemic agents - DPP-4 inhibitors IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects Indications GALVUS ® - Vidagliptin GALVUS ® is a drug useful in the treatment of second-type diabetes mellitus hyperglycemia, in combination with metformin, sulfonylureas and agonists of PPAR gamma, in case of insufficient therapeutic response observed following monotherapy Mechanism of action GALVUS ® - Vidagliptin Vidagliptin

GLIBOMET ® a drug based on Metformin hydrochloride and Glibenclamide. THERAPEUTIC GROUP: Oral hypoglycemic agents, combined therapy IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects Indications GLIBOMET ® - Metformin + Glibenclamide GLIBOMET ® is used as a drug therapy for second type diabetes mellitus, not adequately compensated by diet or sulfonylureas and biguanides. M

GLICOBASE ® is a drug based on acarbose THERAPEUTIC GROUP: Oral anti-diabetics IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects Directions GLICOBASE ® - Acarbose GLICOBASE ® is used as a pharmacological aid to the dietary plan in patients with type II diabetes mellitus, and in combination therapy with insulin in the treatment of the first type diabetic patient. M

What is Glustin? Glustin is a medicine that contains the active substance pioglitazone. The white round tablets contain 15, 30 or 45 mg of pioglitazone. What is Glustin used for? Glustin is used to treat type 2 diabetes (also known as non-insulin-dependent diabetes). It can be used alone (monotherapy) in patients (especially if overweight) who cannot take metformin (an antidiabetic medicine)

GLURENOR ® a drug based on Gliquidone. THERAPEUTIC GROUP: Oral hypoglycemic agents - Sulfonylureas IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects Indications GLURENOR ® - Gliquidone GLURENOR ® is indicated for the treatment of type II diabetes mellitus. M

GLUCOBAY ® is a drug based on acarbose THERAPEUTIC GROUP: Oral anti-diabetics IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects Indications GLUCOBAY ® Acarbosio GLUCOBAY® is indicated in conjunction with an adequate diet in the treatment of type II diabetes mellitus, and in conjunction with insulin therapy in the treatment of type I diabetes. M

What is Glubrava? Glubrava is a medicine available as white and oblong tablets containing two active substances, pioglitazone (15 mg) and metformin hydrochloride (850 mg). The medicine is similar to Competact, which is already authorized in the European Union (EU). The company that makes Competact has agreed that its scientific data will be used for Glubrava

What is Humalog - Insulin lispro? Humalog includes a range of injectable solutions and suspensions supplied in vials, cartridges and pre-filled pens (Humalog Pen, Humaject). The active ingredient is insulin lispro. The Humalog series includes fast-acting insulin solutions (Humalog), protracted insulin suspensions (Humalog NPL) and combinations of both in various proportions (Humalog Mix): Humalog: insulin lispro solution Humalog NPL: suspension of insulin lispro protamine Humalog Mix25: 25% insulin lispro solution and 75% insulin lispro protamine suspension Humalog Mix50: 50% insulin lispro sol

HUMALOG ® a drug based on insulin lispro THERAPEUTIC GROUP: Insulin lispro for injectable use - insulins and analogues. IndicationsAction mechanismStudies and clinical effectiveness Usage and dosage instructionsWarnings Pregnancy and lactationInteractionsContraindicationsUndesirable effects Indications HUMALOG ® - Insulin lispro HUMALOG® is indicated in the treatment of diabetic pathology in adult patients and children who need insulin to adequately control their blood sugar. M